ATE91410T1 - Osmotische dosierungsform. - Google Patents

Osmotische dosierungsform.

Info

Publication number: ATE91410T1
Authority: AT; Austria
Prior art keywords: dosage form; osmotic dosage; osmotic; estrogenic; female
Prior art date: 1989-05-15

Application number

AT90908831T

Other languages

English (en)

Inventor

Jeri Dawn Wright

Jerry D Childers

Brian L Barclay

Patrick S-L Wong

Linda E Atkinson

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-15

Filing date

1990-05-15

Publication date

1993-07-15

1990-05-15 Application filed by Alza Corp filed Critical Alza Corp

1993-07-15 Application granted granted Critical

1993-07-15 Publication of ATE91410T1 publication Critical patent/ATE91410T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Separation Using Semi-Permeable Membranes (AREA)
External Artificial Organs (AREA)
Steroid Compounds (AREA)

AT90908831T 1989-05-15 1990-05-15 Osmotische dosierungsform. ATE91410T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US07/351,365 US4948593A (en)	1989-05-15	1989-05-15	Osmotic dosage form comprising an estrogen and a progestogen
EP90908831A EP0472645B1 (de)	1989-05-15	1990-05-15	Osmotische dosierungsform
PCT/US1990/002749 WO1990014075A1 (en)	1989-05-15	1990-05-15	Osmotic dosage form

Publications (1)

Publication Number	Publication Date
ATE91410T1 true ATE91410T1 (de)	1993-07-15

Family

ID=23380600

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90908831T ATE91410T1 (de)	1989-05-15	1990-05-15	Osmotische dosierungsform.

Country Status (18)

Country	Link
US (1)	US4948593A (de)
EP (1)	EP0472645B1 (de)
JP (1)	JPH04505328A (de)
KR (1)	KR920700619A (de)
AT (1)	ATE91410T1 (de)
AU (1)	AU632824B2 (de)
CA (1)	CA2015709A1 (de)
DE (1)	DE69002235T2 (de)
DK (1)	DK0472645T3 (de)
ES (1)	ES2057570T3 (de)
GR (1)	GR1000391B (de)
IE (1)	IE65154B1 (de)
MX (1)	MX166167B (de)
NO (1)	NO913961L (de)
NZ (1)	NZ233428A (de)
PT (1)	PT94050B (de)
WO (1)	WO1990014075A1 (de)
ZA (1)	ZA903445B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5098714A (en) *	1989-11-16	1992-03-24	Alza Corporation	Osmotic, oral dosage form for fertility control
US5200197A (en) *	1989-11-16	1993-04-06	Alza Corporation	Contraceptive pill
US5208037A (en) *	1991-04-22	1993-05-04	Alza Corporation	Dosage forms comprising polymers comprising different molecular weights
US6277603B1 (en)	1991-12-24	2001-08-21	Isis Pharmaceuticals, Inc.	PNA-DNA-PNA chimeric macromolecules
IL113816A (en) *	1994-06-08	1998-12-06	Akzo Nobel Nv	Pharmaceutical compositions containing desogestrel their preparation and use
US5595759A (en) *	1994-11-10	1997-01-21	Alza Corporation	Process for providing therapeutic composition
US5861431A (en) *	1995-06-07	1999-01-19	Iotek, Inc.	Incontinence treatment
US6110499A (en) *	1997-07-24	2000-08-29	Alza Corporation	Phenytoin therapy
ATE282407T1 (de) *	1997-09-09	2004-12-15	Alza Corp	Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung
US7060734B1 (en)	1997-09-09	2006-06-13	Alza Corporation	Pharmaceutical coating composition and method of use
US6214815B1 (en)	1998-12-23	2001-04-10	Ortho-Mcneil Pharmaceuticals, Inc.	Triphasic oral contraceptive
JP2004140323A (ja) *	2002-08-20	2004-05-13	Sharp Corp	半導体レーザ装置およびその製造方法
ES2523045T3 (es) *	2005-07-12	2014-11-20	Warner Chilcott Company, Llc	Derivado éster de etinil estradiol
CN101228177A (zh) *	2005-07-12	2008-07-23	沃纳奇尔科特公司	雌二醇的3-酯前药

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4344431A (en) *	1969-03-24	1982-08-17	University Of Delaware	Polymeric article for dispensing drugs
US4111202A (en) *	1976-11-22	1978-09-05	Alza Corporation	Osmotic system for the controlled and delivery of agent over time
GB2010676B (en) *	1977-12-27	1982-05-19	Alza Corp	Diffusional drug delivery device with block copolymer as drug carrier
US4449983A (en) *	1982-03-22	1984-05-22	Alza Corporation	Simultaneous delivery of two drugs from unit delivery device
US4764378A (en) *	1986-02-10	1988-08-16	Zetachron, Inc.	Buccal drug dosage form
US4662880A (en) *	1986-03-14	1987-05-05	Alza Corporation	Pseudoephedrine, brompheniramine therapy

1989
- 1989-05-15 US US07/351,365 patent/US4948593A/en not_active Expired - Lifetime
1990
- 1990-04-24 NZ NZ233428A patent/NZ233428A/en unknown
- 1990-04-24 GR GR900100310A patent/GR1000391B/el not_active IP Right Cessation
- 1990-04-30 CA CA002015709A patent/CA2015709A1/en not_active Abandoned
- 1990-05-07 ZA ZA903445A patent/ZA903445B/xx unknown
- 1990-05-11 IE IE170690A patent/IE65154B1/en not_active IP Right Cessation
- 1990-05-15 WO PCT/US1990/002749 patent/WO1990014075A1/en not_active Ceased
- 1990-05-15 DE DE90908831T patent/DE69002235T2/de not_active Expired - Fee Related
- 1990-05-15 AT AT90908831T patent/ATE91410T1/de not_active IP Right Cessation
- 1990-05-15 KR KR1019910701606A patent/KR920700619A/ko not_active Ceased
- 1990-05-15 MX MX020717A patent/MX166167B/es unknown
- 1990-05-15 PT PT94050A patent/PT94050B/pt not_active IP Right Cessation
- 1990-05-15 JP JP2508511A patent/JPH04505328A/ja active Pending
- 1990-05-15 EP EP90908831A patent/EP0472645B1/de not_active Expired - Lifetime
- 1990-05-15 ES ES90908831T patent/ES2057570T3/es not_active Expired - Lifetime
- 1990-05-15 AU AU57414/90A patent/AU632824B2/en not_active Ceased
- 1990-05-15 DK DK90908831.2T patent/DK0472645T3/da active
1991
- 1991-10-10 NO NO91913961A patent/NO913961L/no unknown

Also Published As

Publication number	Publication date
DE69002235T2 (de)	1993-10-28
MX166167B (es)	1992-12-22
KR920700619A (ko)	1992-08-10
PT94050A (pt)	1991-01-08
IE901706L (en)	1990-11-15
JPH04505328A (ja)	1992-09-17
EP0472645B1 (de)	1993-07-14
NO913961D0 (no)	1991-10-10
ZA903445B (en)	1991-02-27
PT94050B (pt)	1996-12-31
EP0472645A1 (de)	1992-03-04
US4948593A (en)	1990-08-14
NO913961L (no)	1991-10-10
NZ233428A (en)	1992-08-26
DK0472645T3 (da)	1993-11-29
AU632824B2 (en)	1993-01-14
CA2015709A1 (en)	1990-11-15
GR1000391B (el)	1992-06-30
AU5741490A (en)	1990-12-18
GR900100310A (en)	1991-10-10
DE69002235D1 (de)	1993-08-19
ES2057570T3 (es)	1994-10-16
IE65154B1 (en)	1995-10-04
WO1990014075A1 (en)	1990-11-29

Legal Events

Date	Code	Title	Description
1994-02-15	UEP	Publication of translation of european patent specification
1998-02-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
FI922206A0 (fi)	1992-05-14	Osmotisk, oral doseringsform foer fertilitets kontroll.
ATE91410T1 (de)	1993-07-15	Osmotische dosierungsform.
IL124472A0 (en)	1998-12-06	Contraceptive process and kit for female mammals comprising a combination of gestagen and estrogen
BG104451A (en)	2000-12-29	Antiestrogen and progestin-containing peroral contraceptives
AU560487B2 (en)	1987-04-09	Contraceptive comprising gestodene and ethinylestradiol
DE69710896D1 (en)	2002-04-11	Progestogen-anti-progestogen therapien
NO976067L (no)	1998-02-27	Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
LU90341I2 (fr)	1999-03-29	75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
NZ333750A (en)	2000-09-29	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
Pharriss et al.	1976	Steroid delivery systems for contraception
Crist	1974	Post-coital estrogen
MX9707009A (es)	1997-11-29	Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.
Briggs	1973	The" morning after" pill